CRANE NXT CO (CXT) Stock Fundamental Analysis

NYSE:CXT • US2244411052

53.25 USD
+0.49 (+0.93%)
At close: Feb 17, 2026
53.25 USD
0 (0%)
After Hours: 2/17/2026, 7:07:53 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CXT. CXT was compared to 122 industry peers in the Electronic Equipment, Instruments & Components industry. While CXT belongs to the best of the industry regarding profitability, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CXT.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year CXT was profitable.
  • In the past year CXT had a positive cash flow from operations.
  • In the past 5 years CXT has always been profitable.
  • CXT had a positive operating cash flow in each of the past 5 years.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • CXT has a Return On Assets of 5.30%. This is in the better half of the industry: CXT outperforms 72.13% of its industry peers.
  • CXT has a better Return On Equity (12.74%) than 80.33% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 8.78%, CXT is in the better half of the industry, outperforming 78.69% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CXT is above the industry average of 8.80%.
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROIC 8.78%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.14%
ROE(5y)16.86%
ROIC(3y)11.44%
ROIC(5y)10.83%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • CXT has a Profit Margin of 9.80%. This is amongst the best in the industry. CXT outperforms 82.79% of its industry peers.
  • CXT's Profit Margin has improved in the last couple of years.
  • CXT's Operating Margin of 17.59% is amongst the best of the industry. CXT outperforms 92.62% of its industry peers.
  • In the last couple of years the Operating Margin of CXT has grown nicely.
  • CXT has a Gross Margin of 43.20%. This is in the better half of the industry: CXT outperforms 75.41% of its industry peers.
  • CXT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
OM growth 3Y-11.5%
OM growth 5Y9.05%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 10 20 30 40

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CXT is creating some value.
  • The number of shares outstanding for CXT has been increased compared to 1 year ago.
  • CXT has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CXT has a worse debt to assets ratio.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.15 indicates that CXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of CXT (2.15) is worse than 60.66% of its industry peers.
  • CXT has a debt to FCF ratio of 6.27. This is a slightly negative value and a sign of low solvency as CXT would need 6.27 years to pay back of all of its debts.
  • CXT's Debt to FCF ratio of 6.27 is in line compared to the rest of the industry. CXT outperforms 57.38% of its industry peers.
  • CXT has a Debt/Equity ratio of 0.89. This is a neutral value indicating CXT is somewhat dependend on debt financing.
  • CXT has a Debt to Equity ratio of 0.89. This is amonst the worse of the industry: CXT underperforms 86.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Altman-Z 2.15
ROIC/WACC0.93
WACC9.43%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that CXT should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.26, CXT is doing worse than 80.33% of the companies in the same industry.
  • A Quick Ratio of 0.94 indicates that CXT may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.94, CXT is doing worse than 80.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. Growth

3.1 Past

  • CXT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.92%.
  • Measured over the past 5 years, CXT shows a small growth in Earnings Per Share. The EPS has been growing by 1.12% on average per year.
  • The Revenue has grown by 11.43% in the past year. This is quite good.
  • Measured over the past years, CXT shows a decrease in Revenue. The Revenue has been decreasing by -9.71% on average per year.
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%

3.2 Future

  • CXT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.53% yearly.
  • The Revenue is expected to grow by 5.38% on average over the next years.
EPS Next Y11.95%
EPS Next 2Y11.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.98%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 13.12, which indicates a correct valuation of CXT.
  • 90.16% of the companies in the same industry are more expensive than CXT, based on the Price/Earnings ratio.
  • CXT is valuated cheaply when we compare the Price/Earnings ratio to 27.16, which is the current average of the S&P500 Index.
  • CXT is valuated reasonably with a Price/Forward Earnings ratio of 11.72.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 91.80% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of CXT to the average of the S&P500 Index (28.10), we can say CXT is valued rather cheaply.
Industry RankSector Rank
PE 13.12
Fwd PE 11.72
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • CXT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CXT is cheaper than 90.98% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CXT is valued cheaper than 85.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.72
EV/EBITDA 9.72
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of CXT may justify a higher PE ratio.
PEG (NY)1.1
PEG (5Y)11.71
EPS Next 2Y11.53%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • CXT has a Yearly Dividend Yield of 1.36%. Purely for dividend investing, there may be better candidates out there.
  • CXT's Dividend Yield is rather good when compared to the industry average which is at 0.47. CXT pays more dividend than 91.80% of the companies in the same industry.
  • CXT's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.36%

5.2 History

  • The dividend of CXT is nicely growing with an annual growth rate of 6.42%!
  • CXT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 24.82% of the earnings are spent on dividend by CXT. This is a low number and sustainable payout ratio.
  • CXT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP24.82%
EPS Next 2Y11.53%
EPS Next 3YN/A
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (2/17/2026, 7:07:53 PM)

After market: 53.25 0 (0%)

53.25

+0.49 (+0.93%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners114.42%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change3.38%
Market Cap3.06B
Revenue(TTM)1.66B
Net Income(TTM)154.70M
Analysts81.82
Price Target94.28 (77.05%)
Short Float %12.64%
Short Ratio9.41
Dividend
Industry RankSector Rank
Dividend Yield 1.36%
Yearly Dividend0.68
Dividend Growth(5Y)6.42%
DP24.82%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.72%
Min EPS beat(2)0.03%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)1.08%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)1.32%
EPS beat(12)10
Avg EPS beat(12)6.53%
EPS beat(16)13
Avg EPS beat(16)6.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)0.56%
Revenue beat(12)6
Avg Revenue beat(12)0.73%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.98%
EPS NY rev (1m)0.04%
EPS NY rev (3m)-1.49%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.54%
Valuation
Industry RankSector Rank
PE 13.12
Fwd PE 11.72
P/S 1.94
P/FCF 17.72
P/OCF 14.1
P/B 2.52
P/tB N/A
EV/EBITDA 9.72
EPS(TTM)4.06
EY7.62%
EPS(NY)4.55
Fwd EY8.54%
FCF(TTM)3.01
FCFY5.64%
OCF(TTM)3.78
OCFY7.09%
SpS27.5
BVpS21.14
TBVpS-9.06
PEG (NY)1.1
PEG (5Y)11.71
Graham Number43.95
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROCE 12.04%
ROIC 8.78%
ROICexc 9.45%
ROICexgc 35.12%
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
FCFM 10.93%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.14%
ROE(5y)16.86%
ROIC(3y)11.44%
ROIC(5y)10.83%
ROICexc(3y)12.73%
ROICexc(5y)12.19%
ROICexgc(3y)46.7%
ROICexgc(5y)44.71%
ROCE(3y)14.96%
ROCE(5y)14.57%
ROICexgc growth 3Y-23.13%
ROICexgc growth 5Y12.65%
ROICexc growth 3Y-18.15%
ROICexc growth 5Y5.03%
OM growth 3Y-11.5%
OM growth 5Y9.05%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Debt/EBITDA 2.86
Cap/Depr 43.72%
Cap/Sales 2.8%
Interest Coverage 5.31
Cash Conversion 57.22%
Profit Quality 111.57%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.15
F-Score4
WACC9.43%
ROIC/WACC0.93
Cap/Depr(3y)44.3%
Cap/Depr(5y)36.54%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.17%
Profit Quality(3y)119.51%
Profit Quality(5y)128.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
EPS Next Y11.95%
EPS Next 2Y11.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%
Revenue Next Year6.98%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.68%
EBIT growth 3Y-5.02%
EBIT growth 5Y-1.54%
EBIT Next Year23.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.61%
FCF growth 3Y-11.36%
FCF growth 5Y-6.44%
OCF growth 1Y2.51%
OCF growth 3Y-7.59%
OCF growth 5Y-4.84%

CRANE NXT CO / CXT FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 8 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


What is the profitability of CXT stock?

CRANE NXT CO (CXT) has a profitability rating of 8 / 10.


How financially healthy is CRANE NXT CO?

The financial health rating of CRANE NXT CO (CXT) is 2 / 10.


Is the dividend of CRANE NXT CO sustainable?

The dividend rating of CRANE NXT CO (CXT) is 6 / 10 and the dividend payout ratio is 24.82%.